948
Views
42
CrossRef citations to date
0
Altmetric
Research Article

WNT/β-catenin pathway is modulated in asthma patients and LPS-stimulated RAW264.7 macrophage cell line

, , &
Pages 56-65 | Received 14 Feb 2011, Accepted 21 Mar 2011, Published online: 24 Jun 2011

References

  • Keshav, S., Chung, L.P., Gordon, S. Macrophage products in inflammation. Diagn. Microbiol. Infect. Dis. 1990, 13, 439–447.
  • Shibata, N., Glass, C.K. Regulation of macrophage function in inflammation and atherosclerosis. J. Lipid Res. 2009, 50 Suppl, S277–S281.
  • Paine, R. 3rd, Preston, A.M., Wilcoxen, S., Jin, H., Siu, B.B., Morris, S.B., Reed, J.A., Ross, G., Whitsett, J.A., Beck, J.M. Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice. J. Immunol. 2000, 164, 2602–2609.
  • Bancroft, G.J., Kelly, J.P., Kaye, P.M., McDonald, V., Cross, C.E. Pathways of macrophage activation and innate immunity. Immunol. Lett. 1994, 43, 67–70.
  • Trinchieri, G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 1995, 13, 251–276.
  • Yan, Z.Q., Hansson, G.K. Innate immunity, macrophage activation, and atherosclerosis. Immunol. Rev. 2007, 219, 187–203.
  • Sweet, M.J., Hume, D.A. Endotoxin signal transduction in macrophages. J. Leukoc. Biol. 1996, 60, 8–26.
  • Carter, A.B., Monick, M.M., Hunninghake, G.W. Lipopolysaccharide-induced NF-kappaB activation and cytokine release in human alveolar macrophages is PKC-independent and TK- and PC-PLC-dependent. Am. J. Respir. Cell Mol. Biol. 1998, 18, 384–391.
  • Kawai, T., Akira, S. TLR signaling. Cell Death Differ. 2006, 13, 816–825.
  • Shapira, L., Takashiba, S., Champagne, C., Amar, S., Van Dyke, T.E. Involvement of protein kinase C and protein tyrosine kinase in lipopolysaccharide-induced TNF-alpha and IL-1 beta production by human monocytes. J. Immunol. 1994, 153, 1818–1824.
  • West, A.P., Koblansky, A.A., Ghosh, S. Recognition and signaling by toll-like receptors. Annu. Rev. Cell Dev. Biol. 2006, 22, 409–437.
  • Wright, G., Singh, I.S., Hasday, J.D., Farrance, I.K., Hall, G., Cross, A.S., Rogers, T.B. Endotoxin stress-response in cardiomyocytes: NF-kappaB activation and tumor necrosis factor-alpha expression. Am. J. Physiol. Heart Circ. Physiol. 2002, 282, H872–H879.
  • Collart, M.A., Baeuerle, P., Vassalli, P. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol. Cell. Biol. 1990, 10, 1498–1506.
  • Hiscott, J., Marois, J., Garoufalis, J., D’Addario, M., Roulston, A., Kwan, I., Pepin, N., Lacoste, J., Nguyen, H., Bensi, G. Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop. Mol. Cell. Biol. 1993, 13, 6231–6240.
  • Libermann, T.A., Baltimore, D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol. Cell. Biol. 1990, 10, 2327–2334.
  • Matsusaka, T., Fujikawa, K., Nishio, Y., Mukaida, N., Matsushima, K., Kishimoto, T., Akira, S. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 10193–10197.
  • Kraus, C., Liehr, T., Hülsken, J., Behrens, J., Birchmeier, W., Grzeschik, K.H., Ballhausen, W.G. Localization of the human beta-catenin gene (CTNNB1) to 3p21: a region implicated in tumor development. Genomics 1994, 23, 272–274.
  • Moon, R.T., Bowerman, B., Boutros, M., Perrimon, N. The promise and perils of Wnt signaling through beta-catenin. Science 2002, 296, 1644–1646.
  • Veeman, M.T., Axelrod, J.D., Moon, R.T. A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev. Cell 2003, 5, 367–377.
  • Wodarz, A., Nusse, R. Mechanisms of Wnt signaling in development. Annu. Rev. Cell Dev. Biol. 1998, 14, 59–88.
  • Cadigan, K.M., Liu, Y.I. Wnt signaling: complexity at the surface. J. Cell. Sci. 2006, 119, 395–402.
  • Willert, K., Nusse, R. Beta-catenin: a key mediator of Wnt signaling. Curr. Opin. Genet. Dev. 1998, 8, 95–102.
  • Huelsken, J., Behrens, J. The Wnt signalling pathway. J. Cell. Sci. 2002, 115, 3977–3978.
  • Duan, Y., Liao, A.P., Kuppireddi, S., Ye, Z., Ciancio, M.J., Sun, J. Beta-catenin activity negatively regulates bacteria-induced inflammation. Lab. Invest. 2007, 87, 613–624.
  • Kim, J.S., Yeo, S., Shin, D.G., Bae, Y.S., Lee, J.J., Chin, B.R., Lee, C.H., Baek, S.H. Glycogen synthase kinase 3beta and beta-catenin pathway is involved in toll-like receptor 4-mediated NADPH oxidase 1 expression in macrophages. FEBS J. 2010, 277, 2830–2837.
  • Monick, M.M., Carter, A.B., Robeff, P.K., Flaherty, D.M., Peterson, M.W., Hunninghake, G.W. Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of beta-catenin. J. Immunol. 2001, 166, 4713–4720.
  • Thiele, A., Wasner, M., Müller, C., Engeland, K., Hauschildt, S. Regulation and possible function of beta-catenin in human monocytes. J. Immunol. 2001, 167, 6786–6793.
  • Wang, H., Garcia, C.A., Rehani, K., Cekic, C., Alard, P., Kinane, D.F., Mitchell, T., Martin, M. IFN-beta production by TLR4-stimulated innate immune cells is negatively regulated by GSK3-beta. J. Immunol. 2008, 181, 6797–6802.
  • Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am. Rev. Respir. Dis. 1987, 136, 225–244.
  • Bousquet, J., Clark, T.J., Hurd, S., Khaltaev, N., Lenfant, C., O’byrne, P., Sheffer, A. GINA guidelines on asthma and beyond. Allergy 2007, 62, 102–112.
  • Hersperger, R., Buchheit, K.H., Cammisuli, S., Enz, A., Lohse, O., Ponelle, M., Schuler, W., Schweitzer, A., Walker, C., Zehender, H., Zenke, G., Zimmerlin, A.G., Zollinger, M., Mazzoni, L., Fozard, J.R. A locally active antiinflammatory macrolide (MLD987) for inhalation therapy of asthma. J. Med. Chem. 2004, 47, 4950–4957.
  • Weinbrenner, A., Hüneke, D., Zschiesche, M., Engel, G., Timmer, W., Steinijans, V.W., Bethke, T., Wurst, W., Drollmann, A., Kaatz, H.J., Siegmund, W. Circadian rhythm of serum cortisol after repeated inhalation of the new topical steroid ciclesonide. J. Clin. Endocrinol. Metab. 2002, 87, 2160–2163.
  • Livak, K.J., Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−delta delta C(T)) method. Methods 2001, 25, 402–408.
  • Kim, S.Y., Dunn, I.F., Firestein, R., Gupta, P., Wardwell, L., Repich, K., Schinzel, A.C., Wittner, B., Silver, S.J., Root, D.E., Boehm, J.S., Ramaswamy, S., Lander, E.S., Hahn, W.C. CK1epsilon is required for breast cancers dependent on beta-catenin activity. PLoS ONE 2010, 5, e8979.
  • Wang, Y., Liu, S., Zhu, H., Zhang, W., Zhang, G., Zhou, X., Zhou, C., Quan, L., Bai, J., Xue, L., Lu, N., Xu, N. FRAT1 overexpression leads to aberrant activation of beta-catenin/TCF pathway in esophageal squamous cell carcinoma. Int. J. Cancer 2008, 123, 561–568.
  • von Asmuth, E.J., Dentener, M.A., Ceska, M., Buurman, W.A. IL-6, IL-8 and TNF production by cytokine and lipopolysaccharide-stimulated human renal cortical epithelial cells in vitro. Eur. Cytokine Netw. 1994, 5, 301–310.
  • Romero, L.I., Schettini, G., Lechan, R.M., Dinarello, C.A., Reichlin, S. Bacterial lipopolysaccharide induction of IL-6 in rat telencephalic cells is mediated in part by IL-1. Neuroendocrinology 1993, 57, 892–897.
  • Jirik, F.R., Podor, T.J., Hirano, T., Kishimoto, T., Loskutoff, D.J., Carson, D.A., Lotz, M. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J. Immunol. 1989, 142, 144–147.
  • Guha, M., Mackman, N. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J. Biol. Chem. 2002, 277, 32124–32132.
  • Diya, Z., Lili, C., Shenglai, L., Zhiyuan, G., Jie, Y. Lipopolysaccharide (LPS) of Porphyromonas gingivalis induces IL-1beta, TNF-alpha and IL-6 production by THP-1 cells in a way different from that of Escherichia coli LPS. Innate Immun. 2008, 14, 99–107.
  • Hirotani, T., Lee, P.Y., Kuwata, H., Yamamoto, M., Matsumoto, M., Kawase, I., Akira, S., Takeda, K. The nuclear IkappaB protein IkappaBNS selectively inhibits lipopolysaccharide-induced IL-6 production in macrophages of the colonic lamina propria. J. Immunol. 2005, 174, 3650–3657.
  • Gray, S., Feinberg, M.W., Hull, S., Kuo, C.T., Watanabe, M., Sen-Banerjee, S., DePina, A., Haspel, R., Jain, M.K. The Krüppel-like factor KLF15 regulates the insulin-sensitive glucose transporter GLUT4. J. Biol. Chem. 2002, 277, 34322–34328.
  • George, S.J. Wnt pathway: a new role in regulation of inflammation. Arterioscler. Thromb. Vasc. Biol. 2008, 28, 400–402.
  • Pereira, C.P., Bachli, E.B., Schoedon, G. The wnt pathway: a macrophage effector molecule that triggers inflammation. Curr. Atheroscler. Rep. 2009, 11, 236–242.
  • Gong, R., Rifai, A., Ge, Y., Chen, S., Dworkin, L.D. Hepatocyte growth factor suppresses proinflammatory NFkappaB activation through GSK3beta inactivation in renal tubular epithelial cells. J. Biol. Chem. 2008, 283, 7401–7410.
  • Tetsu, O., McCormick, F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999, 398, 422–426.
  • Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D’Amico, M., Pestell, R., Ben-Ze’ev, A. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 5522–5527.
  • Caillaud, D., Evrard, B., Laurichesse, H., Souweine, B. [Role of indoor endotoxins in asthma symptoms]. Rev. Mal. Respir. 2009, 26, 893–899.
  • Kuo Chou, T.N., Li, Y.S., Lue, K.H., Liao, C.F., Lin, C.Y., Tzeng, P.R., Wong, R.H. Genetic polymorphism of manganese superoxide dismutase is associated with childhood asthma. J. Asthma 2010, 47, 532–538.
  • Barnes, P.J., Adcock, I.M. Transcription factors and asthma. Eur. Respir. J. 1998, 12, 221–234.
  • Marini, M., Vittori, E., Hollemborg, J., Mattoli, S. Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. J. Allergy Clin. Immunol. 1992, 89, 1001–1009.
  • Kraus-Filarska, M., Malolepszy, J., Medrala, W., Dobek, R. Bacterial lipopolysaccharide-induced sulfidoleukotriene release from peripheral blood leukocytes in patients with asthma and chronic obstructive pulmonary disease. J. Investig. Allergol. Clin. Immunol. 1998, 8, 94–97.
  • Kawahara, T., Kohjima, M., Kuwano, Y., Mino, H., Teshima-Kondo, S., Takeya, R., Tsunawaki, S., Wada, A., Sumimoto, H., Rokutan, K. Helicobacter pylori lipopolysaccharide activates Rac1 and transcription of NADPH oxidase Nox1 and its organizer NOXO1 in guinea pig gastric mucosal cells. Am. J. Physiol., Cell Physiol. 2005, 288, C450–C457.
  • Lee, J.G., Lim, E.J., Park, D.W., Lee, S.H., Kim, J.R., Baek, S.H. A combination of Lox-1 and Nox1 regulates TLR9-mediated foam cell formation. Cell. Signal. 2008, 20, 2266–2275.
  • Rokutan, K., Kawahara, T., Kuwano, Y., Tominaga, K., Sekiyama, A., Teshima-Kondo, S. NADPH oxidases in the gastrointestinal tract: a potential role of Nox1 in innate immune response and carcinogenesis. Antioxid. Redox Signal. 2006, 8, 1573–1582.
  • Akashi, K., Hayashi, S., Gondo, H., Mizuno, S., Harada, M., Tamura, K., Yamasaki, K., Shibuya, T., Uike, N., Okamura, T. Involvement of interferon-gamma and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults. Br. J. Haematol. 1994, 87, 243–250.
  • Cline, M.J. Histiocytes and histiocytosis. Blood 1994, 84, 2840–2853.
  • Osugi, Y., Hara, J., Tagawa, S., Takai, K., Hosoi, G., Matsuda, Y., Ohta, H., Fujisaki, H., Kobayashi, M., Sakata, N., Kawa-Ha, K., Okada, S., Tawa, A. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood 1997, 89, 4100–4103.
  • Nakagawa, R., Naka, T., Tsutsui, H., Fujimoto, M., Kimura, A., Abe, T., Seki, E., Sato, S., Takeuchi, O., Takeda, K., Akira, S., Yamanishi, K., Kawase, I., Nakanishi, K., Kishimoto, T. SOCS-1 participates in negative regulation of LPS responses. Immunity 2002, 17, 677–687.
  • Mashima, R., Saeki, K., Aki, D., Minoda, Y., Takaki, H., Sanada, T., Kobayashi, T., Aburatani, H., Yamanashi, Y., Yoshimura, A. FLN29, a novel interferon- and LPS-inducible gene acting as a negative regulator of toll-like receptor signaling. J. Biol. Chem. 2005, 280, 41289–41297.
  • Kidd, P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern. Med. Rev. 2003, 8, 223–246.
  • Crane, I.J., Forrester, J.V. Th1 and Th2 lymphocytes in autoimmune disease. Crit. Rev. Immunol. 2005, 25, 75–102.
  • Larché, M., Robinson, D.S., Kay, A.B. The role of T lymphocytes in the pathogenesis of asthma. J. Allergy Clin. Immunol. 2003, 111, 450–63; quiz 464.
  • Maggi, E. The TH1/TH2 paradigm in allergy. Immunotechnology 1998, 3, 233–244.
  • Diehl, S., Rincón, M. The two faces of IL-6 on Th1/Th2 differentiation. Mol. Immunol. 2002, 39, 531–536.
  • Yachida, M., Kurokohchi, K., Arima, K., Nishioka, M. Increased bcl-2 expression in lymphocytes and its association with hepatocellular damage in patients with autoimmune hepatitis. Clin. Exp. Immunol. 1999, 116, 140–145.
  • Ye, B.H., Cattoretti, G., Shen, Q., Zhang, J., Hawe, N., de Waard, R., Leung, C., Nouri-Shirazi, M., Orazi, A., Chaganti, R.S., Rothman, P., Stall, A.M., Pandolfi, P.P., Dalla-Favera, R. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat. Genet. 1997, 16, 161–170.
  • Chalaris, A., Garbers, C., Rabe, B., Rose-John, S., Scheller, J. The soluble interleukin 6 receptor: generation and role in inflammation and cancer. Eur. J. Cell Biol. 2010; DOI10.1016.
  • Rabe, B., Chalaris, A., May, U., Waetzig, G.H., Seegert, D., Williams, A.S., Jones, S.A., Rose-John, S., Scheller, J. Transgenic blockade of interleukin 6 transsignaling abrogates inflammation. Blood 2008, 111, 1021–1028.
  • Rose-John, S., Waetzig, G.H., Scheller, J., Grötzinger, J., Seegert, D. The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin. Ther. Targets 2007, 11, 613–624.
  • Doganci, A., Sauer, K., Karwot, R., Finotto, S. Pathological role of IL-6 in the experimental allergic bronchial asthma in mice. Clin. Rev. Allergy Immunol. 2005, 28, 257–270.
  • Whiteley, W., Jackson, C., Lewis, S., Lowe, G., Rumley, A., Sandercock, P., Wardlaw, J., Dennis, M., Sudlow, C. Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. PLoS Med. 2009, 6, e1000145.
  • Tso, A.R., Merino, J.G., Warach, S. Interleukin-6 174G/C polymorphism and ischemic stroke: a systematic review. Stroke. 2007, 38, 3070–3075.
  • Imanifooladi, A.A., Yazdani, S., Nourani, M.R. The role of nuclear factor-kappaB in inflammatory lung disease. Inflamm. Allergy Drug Targets 2010, 9, 197–205.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.